| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |